Micotherapy BM
Micotherapy BM es un complemento alimenticio que contiene Ganoderma lucidum de agricultura ecológica, Hypericum perforatum, Centella asiatica, Passiflora incarnata y vitaminas del grupo B, formulado para la relajación y el bienestar mental.
Formato
60 cápsulas gastrorresistentes DRcaps™
Modo de empleo
2-4 cápsulas al día
Propiedades
Micotherapy BM une la tradición de uso de la micoterapia con la de la fitoterapia. La Pasiflora y el Hipérico se utilizan tradicionalmente para la relajación, el bienestar mental y el estado de ánimo; la Pasiflora también para favorecer el sueño. Las vitaminas del grupo B (B1, B6, B12, niacina, ácido fólico) contribuyen a la función psicológica normal y al funcionamiento normal del sistema nervioso.
Efectos principales
Favorece la relajación y el bienestar mental, contribuyendo a mejorar el equilibrio psicofísico, el tono del estado de ánimo y los ritmos del sueño
Información nutricional
| Componentes |
Por dosis diaria |
|---|---|
| Reishi extracto seco | 660 mg |
| Aporte de polisacáridos | 165 mg |
| Trigo sarraceno | 400 mg |
| Hipérico extracto seco | 234 mg |
| Aporte diario de hipericina | 0,7 mg |
| Relación hiperforina/hipericina | no superior a 7 |
| Pasiflora extracto seco | 200 mg |
| Centella extracto seco | 100 mg |
| Vitamina B1 (tiamina) | 0,8 mg |
| Vitamina B2 (riboflavina) | 1,3 mg |
| Vitamina B3 (niacina) | 14,3 mg |
| Vitamina B5 (ác. pantoténico) | 5,5 mg |
| Vitamina B6 (piridoxina) | 0,8 mg |
| Ácido fólico | 180 mcg |
| Vitamina B12 (cianocobalamina) | 1,6 mcg |
Dónde encontrar el producto
Código de parafarmacia: A925603779
Inscrito en el registro de complementos alimenticios del Ministerio de Sanidad italiano, n.º: codice 71757
Notas:
las sustancias presentes en el Hypericum perforatum pueden interactuar con diversas enzimas responsables del metabolismo de los fármacos. Se recomienda consultar al médico antes de tomar preparados a base de hipérico junto con otros medicamentos
Mizuno, T. (1996). Oriental Medicinal tradition of “Ganoderma lucidum (Reishi)” in China. In T. Mizuno & B.-K. Kim(Eds.), Ganoderma lucidum (pp. 101-106). Seoul, Korea : IlYang Pharm. Co. Ltd
Kim KC, Kim IG. Ganoderma lucidum extract protects DNA from strand breakage caused by hydroxyl radical and UV irradiation. Int J Mol Med 1999 Sep;4(3):273-7
Wachtel-Galor S, Szeto YT, Tomlinson B, et al. Ganoderma lucidum (‘Lingzhi’); acute and short-term biomarker response to supplementation. Int J Food Sci Nutr. Feb 2004;55(1):75-83
T.A. Ajith, N.P. Sudheesh, D. Roshny, G. Abishek and K.K. Janardhanan. Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats Experimental Gerontology Volume 44, Issue 3, March 2009, Pages 219-223
Tang W, Gao Y, Chen G, et al. A Randomized, Double-Blind and Placebo-Controlled Study of a Ganoderma lucidum Polysaccharide Extract in Neurasthenia. J Med Food. 2005;8:53-58
CS Lai, MS Yu, WH Yuen, KF So, SY Zee, and RC Chang. Antagonizing beta-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res, Jan 2008; 1190: 215-24
R Zhang, S Xu, Y Cai, M Zhou, X Zuo and P Chan. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration Through Inhibition of Microglial Activation. eCAM Advance Access published July 16, 2009
ZY Zhou, YP Tang, J Xiang, P Wua, HM Jin, Z Wang, M Mori, and DF Cai. Neuroprotective effects of water-soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. J Ethnopharmacol, August 19, 2010; 131(1): 154-64
Zhou Y, Qu ZQ, Zeng YS, Lin YK, Li Y, Chung P, Wong R, Hagg U. Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Exp Toxicol Pathol, November 1, 2012; 64(7-8): 673-80
Ajith TA et al. Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats. ExpGerontol 2009; 44(3):219-223
Ding H, et al. Ganoderma lucidum extract protects dopaminergic neurons through inhibiting the production of inflammatory mediators by activated microglia. Sheng Li Xue Bao. 2010 Dec 25;62(6):547-54
Zhao HB, et al. Polysaccharide extract isolated from ganoderma lucidum protects rat cerebral cortical neurons from hypoxia/reoxygenation injury. J Pharmacol Sci. 2004 Jun;95(2):294-8
Zhang R, et al. Ganoderma lucidum protects dopaminergic neuron degeneration through inhibition of microglial activation. Evid Based Complement Alternat Med. 2011;2011:156810
Chen LW, Horng LY, Wu CL, Sung HC, Wu RT. Activating mitochondrial regulator PGC-1alpha expression by astrocytic NGF is a therapeutic strategy for Huntington’s disease. Neuropharmacology. 2012 May 24
XY Cui, SY Cui, J Zhang, ZJ Wang, B Yu, ZF Sheng, XQ Zhang, and YH Zhang Extract of Ganoderma lucidum prolongs sleep time in rats. J Ethnopharmacol, February 15, 2012; 139(3): 796-800
Lee JM et al. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytotherapy Res; 15: 245-249
Campanini E. – “ Dizionario di fitoterapia e piante medicinali”– Milano, 2012
Fassina G. – “Lezioni di farmacologia”- Cedam, Padova, 1995
Speroni E. et al. Neuropharmacological activity of extracts from Passiflora incarnata. Planta Med. 54, 488-491, 1988
Bourin A.V. et al. A combination of plant extracts in the treatment of outpatients with adjustement disorders with anxious mood. Controlled study versus placebo. Fundam. Clin. Pharmacol. 11, 127-132, 1997
Speroni E. et al. Role of chrisin in the sedative effects of Passiflora incarnata L. Phytother. Res. 10, suppl. 1, S 98- S 100, 1996
Speroni E. et al. Sedative effects of crude extracts of Passiflora incarnata after oral administration. Phytother. Res. 10, suppl. 1, S 92-S 94, 1996
Dhawan K. et al. Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia 72, 922-926, 2001
Dhawan K. et al. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J. Ethnopharmacol. 78, 165-170, 2001
Akhondzadek S. et al. Passionflower in the treatment of generalized anxiety: a pilot double blind randomized controlled trial with oxazepam. J. Clin. Pharm. Ther. 26, 363-377, 2001
Dhawan K. et al. Comparative Anxiolytic Activity Profile of Various Preparations of Passiflora incarnata Linneaus: A Comment on Medicinal Plants’ Standardization. J Altern Complement Med 8(3):283-91, 2002
A Szegedi, R Kohnen, A Dienel, M Kieser. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John’s wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ 2005;330:503
Monograph. Hypericum perforatum. Altern Med Rev. 2004 Sep; 9 (3):318-25
Linde K, Mulrow CD, Berner M, Egger M. St John’s worth for depression. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000448
James, J.T.; Dubery, I.A. Pentacyclic Triterpenoids from the Medicinal Herb, Centella asiatica (L.) Urban. Molecules 2009, 14, 3922-3941
Blumenthal M et al. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Klein S, Rister RS, translators. Austin (TX): American Botanical Council; Boston (MA): Integrative Medicine Communications; 1998
Líneas de productos
